Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 1
2006 1
2007 2
2008 4
2009 5
2010 2
2011 5
2012 8
2013 9
2014 5
2015 6
2016 4
2017 5
2018 9
2019 7
2020 3
2021 5
2022 8
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean young woo choi (54 results)?
Treatable traits in the NOVELTY study.
Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A, Pavord ID, van den Berge M, Faner R; NOVELTY Study Investigators. Agustí A, et al. Respirology. 2022 Nov;27(11):929-940. doi: 10.1111/resp.14325. Epub 2022 Jul 21. Respirology. 2022. PMID: 35861464 Free PMC article.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.
Hughes R, Rapsomaniki E, Bansal AT, Vestbo J, Price D, Agustí A, Beasley R, Fageras M, Alacqua M, Papi A, Müllerová H, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Hughes R, et al. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2803-2811. doi: 10.1016/j.jaip.2023.05.013. Epub 2023 May 23. J Allergy Clin Immunol Pract. 2023. PMID: 37230383 Free article.
WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Bhavsar P, Adcock I, Chung KF, Kim TB. Pham DD, et al. Among authors: cho yj. Ann Allergy Asthma Immunol. 2023 Jun 1:S1081-1206(23)00402-7. doi: 10.1016/j.anai.2023.05.029. Online ahead of print. Ann Allergy Asthma Immunol. 2023. PMID: 37268246
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study.
Shim JS, Kim H, Kwon JW, Park SY, Kim S, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Kim SH, Park SY, Cho YJ, Park CS, Jung JW, Park HK, Kim JH, Choi JH, Moon JY, Adcock I, Chung KF, Kim MH, Kim TB; Precision Intervention in Severe Asthma (PRISM) study investigatorsa. Shim JS, et al. Among authors: cho yj. World Allergy Organ J. 2023 Dec 12;16(12):100848. doi: 10.1016/j.waojou.2023.100848. eCollection 2023 Dec. World Allergy Organ J. 2023. PMID: 38093952 Free PMC article.
93 results